Phase I/II clinical study of α-galactosylceramide-pulsed antigen presenting cells as adjuvant immunotherapy for patients with head and neck mucosal malignant melanoma after carbon ion radiotherapy.
Phase I/II clinical study of α-galactosylceramide-pulsed antigen presenting cells as adjuvant immunotherapy for patients with head and neck mucosal malignant melanoma after carbon ion radiotherapy.
复制标题
α-半乳糖神经酰胺脉冲抗原呈递细胞作为碳离子放射治疗后头颈部粘膜恶性黑色素瘤患者辅助免疫治疗的 I/II 期临床研究。
DOI：
--
复制
发表时间：
2013
期刊：
影响因子：
--
通讯作者：
T.
中科院分区：
文献类型：
--
作者：
Fujikawa;A.;Kunii;N.;Horinaka;A.;Makita;Y.;Uchida;R.;Ihara;F.;Motohashi;S.;Okamoto;Y.;and Nakayama;T.
